← Open Payments lookup

JESSICA DAVIS: Open Payments

NPI 1174063309 · GADSDEN, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$565 in 28 payments from 10 companies in 2025. Trend: 2023 $302 · 2024 $180 · 2025 $565

Food & beverage: $565
CompanyPaymentsAmount
ABBVIE INC.15$205
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$111
Mindray DS USA, Inc.1$66
Alkermes, Inc.3$57
E.R. Squibb & Sons, L.L.C.2$39
Otsuka America Pharmaceutical, Inc.1$22
Supernus Pharmaceuticals, Inc.1$18
Vanda Pharmaceuticals Inc.1$17
Neurocrine BioSciences, Inc.1$17
Janssen Pharmaceuticals, Inc1$14

Products named: VRAYLAR, CAPLYTA, PATIENT MONITOR, ARISTADA, COBENFY, REXULTI, Qelbree, FANAPT.

Industry payments across AL — which companies pay providers there.